Serveur d'exploration sur la grippe aux Pays-Bas

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Huib W K F H. Scheijbeler - Marianne L L. Van Genugten

Terms

2Huib W K F H. Scheijbeler
4Marianne L L. Van Genugten
2Jan C. Wilschut
9Maarten J. Postma
3Anna K. Lugnér

Associations

Freq.WeightAssociation
20.707Huib W K F H. Scheijbeler - Marianne L L. Van Genugten
20.471Huib W K F H. Scheijbeler - Maarten J. Postma
20.471Jan C. Wilschut - Maarten J. Postma
20.385Anna K. Lugnér - Maarten J. Postma
20.333Maarten J. Postma - Marianne L L. Van Genugten

Documents par ordre de pertinence
000318 (2007) Maarten J. Postma [Pays-Bas] ; Annoesjka Novak ; Huib W K F H. Scheijbeler ; Marlene Gyldmark ; Marianne L L. Van Genugten ; Jan C. WilschutCost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands.
000354 (2005) Maarten J. Postma [Pays-Bas] ; Paul Jansema ; Huib W K F H. Scheijbeler ; Marianne L L. Van GenugtenScenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults.
000181 (2012) Anna K. Lugnér [Pays-Bas] ; Michiel Van Boven ; Robin De Vries ; Maarten J. Postma ; Jacco WallingaCost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
000223 (2010) Eelko Hak [Pays-Bas] ; Lisanne M. Knol ; Jan C. Wilschut ; Maarten J. Postma[Influenza vaccination of hospital healthcare staff from the perspective of the employer: a positive balance].
000264 (2009) Anna K. Lugnér [Pays-Bas] ; Maarten J. PostmaInvestment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.
000039 (2018) Maartje S. Jacobs [Pays-Bas] ; Femke Kaasenbrood [Pays-Bas] ; Maarten J. Postma [Pays-Bas] ; Marinus Van Hulst [Pays-Bas] ; Robert G. Tieleman [Pays-Bas]Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
000149 (2013) Giedre Gefenaite [Pays-Bas] ; Margot Tacken ; Jens Bos ; Irina Stirbu-Wagner ; Joke C. Korevaar ; Ronald P. Stolk ; Bert Wolters ; Marc Bijl ; Maarten J. Postma ; Jan Wilschut ; Kristin L. Nichol ; Eelko HakEffectiveness of A(H1N1)pdm09 influenza vaccine in adults recommended for annual influenza vaccination.
000182 (2012) Josien Riphagen-Dalhuisen [Pays-Bas] ; Joep C F. Kuiphuis ; Arjen R. Procé ; Willem Luytjes ; Maarten J. Postma ; Eelko HakContributing factors to influenza vaccine uptake in general hospitals: an explorative management questionnaire study from the Netherlands.
000242 (2010) Anna K. Lugnér [Pays-Bas] ; Sido D. Mylius ; Jacco WallingaDynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.
000374 (2004) Marianne L L. Van Genugten [Pays-Bas] ; Marie-Louise A. HeijnenThe expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands.
000405 (2003) Maarten J. Postma [Pays-Bas] ; Marie-Louise A. Heijnen ; Philippe Beutels ; Johannes C. JagerPharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands.
000406 (2003) Marianne L L. Van Genugten [Pays-Bas] ; Marie-Louise A. Heijnen ; Johannes C. JagerPandemic influenza and healthcare demand in the Netherlands: scenario analysis.

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 10:18:30 2020. Site generation: Sat Mar 27 13:53:34 2021